Vital KSK Holdings, Inc. (TYO:3151)

Market Cap	74.65B +15.7%
Revenue (ttm)	610.50B +1.7%
Net Income	7.36B +0.7%
EPS	152.28 +2.2%
Shares Out	48.38M
PE Ratio	10.13
Forward PE	n/a
Dividend	68.00 (4.30%)
Ex-Dividend Date	Mar 30, 2026

Volume	8,600
Open	1,536.00
Previous Close	1,543.00
Day's Range	1,510.00 - 1,536.00
52-Week Range	1,178.00 - 1,649.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About Vital KSK Holdings

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Employees: 3,756
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3151

Financial Performance

In fiscal year 2026, Vital KSK Holdings's revenue was 610.50 billion, an increase of 1.69% compared to the previous year's 600.37 billion. Earnings were 7.36 billion, an increase of 0.74%.